Array BioPharma to raise $225M through stock sale
BOULDER -- Array BioPharma Inc. (Nasdaq: ARRY) announced the pricing of an underwritten public offering of 20,930,232 shares of its common stock at a public offering price of$10.75per share. ... Read More
Friday September 15, 2017 0 comments
Array BioPharma announces FDA acceptance to review new melanoma drug applications
BOULDER -- Array BioPharma (Nasdaq: ARRY) announced the U.S. Food and Drug Administration (FDA) has accepted for review its New Drug Applications (NDAs) to support use of the combination of... Read More
Wednesday September 13, 2017 0 comments
Array BioPharma and Amgen collaborate to develop autoimmune drugs
BOULDER/THOUSAND OAKS, Calif. -- California-based Amgen (NASDAQ:AMGN) and Boulder-based Array BioPharma (NASDAQ:ARRY) today announced a collaboration agreement for the discovery and development... Read More
Wednesday July 19, 2017 0 comments
Array BioPharma submits New Drug Applications to FDA for binimetinib and encorafenib in advanced melanoma treatment
BOULDER -- Array BioPharma (Nasdaq:ARRY) today announced the submission of two New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) to support use of the combination of... Read More
Wednesday July 5, 2017 0 comments
Array BioPharma and Bristol-Myers Squibb announce strategic research collaboration
BOULDER andNEW YORK CITY -- Array BioPharma (Nasdaq: ARRY) and Bristol-Myers Squibb Company (NYSE:BMY) announced the companies have entered into a clinical research collaboration to investigate... Read More
Thursday June 1, 2017 0 comments
Array BioPharma announces strategic collaboration with Merck
BOULDER -- Array BioPharma Inc .(Nasdaq: ARRY) announced it has entered into a clinical trial collaboration agreement with Merck (known as MSD outsidethe United StatesandCanada) to investigate... Read More
Tuesday May 9, 2017 0 comments
Array BioPharma closes on stock sale raising $132.25M
BOULDER -- Array BioPharma Inc . (NasdaqGM: ARRY) today announced the closing of its underwritten public offering of 21,160,000 shares of its common stock, which includes 2,760,000 shares of... Read More
Wednesday October 5, 2016 0 comments
Array BioPharma selling 18.4M shares of stock to raise $115M to fund R&D
BOULDER -- Array BioPharma Inc. (Nasdaq: ARRY) today announced the pricing of an underwritten public offering of 18,400,000 shares of its common stock at a public offering price of $6.25per... Read More
Wednesday September 28, 2016 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
